A resolution designating November 2023 as American Diabetes Month.
SRES 474 designates November 2023 as American Diabetes Month to promote public awareness of diabetes prevention, treatment, and early detection. The resolution highlights the high prevalence of diabetes in the U.S. (affecting ~37 million people), disproportionate impacts on racial and ethnic groups, and significant economic costs (e.g., $412 billion in 2022). It emphasizes education on risk factors like age, weight, family history, and healthcare barriers, while supporting research and prevention efforts. This non-binding resolution does not create new laws or funding but aims to elevate national focus on diabetes management and equity.
Bill status
passed
3 of 5 stages cleared
Introduction
Nov 2023
Committee Review
Senate Passage
Nov 2023
House Passage
President
Introduced Nov 27, 2023
Last action Nov 27, 2023
Floor votes
How they voted
This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history
Actions timeline
Total actions
3
Key actions
1
Committee
0
Amendments
1
Nov 27, 2023
Introduced
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S5617; text: CR S5600-5601)
upper
Nov 27, 2023
Upper · Passed
Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S5617; text: CR S5600-5601)
upper
Nov 27, 2023
Introduced
Introduced in Senate
upper
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about SRES 474
Scope: US
Hi! I can help you understand SRES 474. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline